Public Health Agency of Canada / Agence de sant‚ publique du Canada
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m Skip all navigation -accesskey z
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors Health Surveillance Health Canada
Canada Communicable Disease Report
  

Volume: 26S3 - May 2000

Case Definitions for Diseases Under National Surveillance

PDF Version PDF
(73 Pages, 1,827 KB)


Document

PREFACE

This document is the product of close cooperation between the Laboratory Centre for Disease Control, of Health Canada, and the communicable disease control epidemiologists in each province and territory. This cooperation is achieved through the Advisory Committee on Epidemiology (ACE), which is a forum for these provincial and territorial officials to advise their federal counterparts on matters related to the study and control of diseases. ACE decided in 1997 to review communicable disease surveillance in Canada. The review process resulted in this document.

Diseases Under National Surveillance

BASIC PRINCIPLES AND METHODS

Goals

  1. To facilitate the control of the disease under surveillance by identifying the following:

    a. Prevailing incidence levels, impacts and trends to assist in the development of feasible objectives for prevention and control of the disease and the evaluation of control programs.

    b. Epidemiologic patterns and risk factors associated with the disease to assist in the development of intervention strategies.

    c. Outbreaks for the purpose of timely investigation and control.

  2. To satisfy the needs of government (especially regulatory programs), health care professionals, voluntary agencies and the public for information on risk patterns and trends in the occurrence of communicable diseases.

Quality

If surveillance is considered necessary for any particular disease, then the surveillance must be carried out in such a way as to be of the highest epidemiologic quality. This implies the following:

  1. Use of a uniform case definition across Canada and definition of a preventable case if applicable.

  2. Collection of sufficient, appropriate epidemiologic data on each case to fulfil goal number one and identify preventable cases.

  3. Timely transmission of these data from local to provincial and national agencies for analysis. Personal identifying information should be deleted before the data reach the federal level.

  4. Use of the data to enhance control programs and assist in the development of realistic objectives for reducing the number of preventable cases.

  5. Periodic effectiveness and economic evaluation of the surveillance system and progress towards control of the disease.

We realize that full implementation will require a gradual phase-in period and will proceed at different rates in different jurisdictions.

Reporting of Diseases Under National Surveillance

In Canada, the reporting or notifying of diseases is mandated by provincial legislation, and the list of notifiable diseases differs by province/territory. Prior to 1990, each jurisdiction had its own set of case definitions, and comparability across jurisdictions was difficult, if not impossible. In March 1991, the Laboratory Centre for Disease Control (LCDC), in conjunction with the provincial and territorial epidemiologists, published disease-specific case definitions for diseases under national surveillance. For the first time, these case definitions provided standardized criteria for the reporting of cases under national surveillance. This second edition of case definitions should supersede the 1991 edition.

In most instances, only confirmed cases are reported; a combination of clinical, laboratory and epidemiologic criteria is used to classify a confirmed case. For example, a confirmed case of a vaccine-preventable disease uses both a laboratory definition and an epidemiologic one (clinical illness in a person epidemiologically linked to a laboratory-confirmed case). Some case definitions include a brief clinical description; however, this information is intended for the purpose of classifying cases and should not be used for clinical diagnoses.

Probable cases may be described to assist local public health authorities in carrying out their public health mandate, such as outbreak investigation and contact tracing.

Physicians diagnosing a case of a specific (notifiable) disease report their clinical diagnosis with/without laboratory confirmation to local health authorities. These authorities are responsible for determining that the case meets the surveillance case definition before they officially report the case. Where there is uncertainty because data are missing or the results are inconclusive, it may be reported as a possible case, but the status must be made definite later; if not, the case must be deleted from the reporting system. The local health authority reporting the case collects all necessary epidemiologic data on it.

All pertinent laboratory detections (from appropriate sites) must be reported to local health authorities, which will then contact the physician to determine whether the isolate/specimen came from a person who meets the case definition. If so, the case is reported and the necessary epidemiologic data are gathered by the health authority.

The reporting of a case should be timely and need not be delayed until all epidemiologic data are available. Such data may be reported later and added to the original case report centrally. While local health authorities are encouraged to collect all information requested by the reporting system, when some items are not available the case should be reported with missing items listed as unknown. A case should never go unreported or deleted because of missing data. The only exception is when data to determine whether the case meets the case definition are missing. Such cases should not be reported.

The "Core Set" of Variables

The Advisory Committee on Epidemiology has agreed on "the necessary epidemiologic data" to be gathered for each reported case. This "core set of variables" includes province, disease, a unique identifier, age, gender, confirmed status (laboratory confirmed or epidemiologically linked), episode date, and geographic indicator.

Reporting of Case-by-Case Data

The Advisory Committee on Epidemiology has agreed to report case-by-case data, effective January 2000. Currently, some provinces/territories report aggregate data and some report case-by-case. Case-by-case reporting is "line-listed" information or, in other words, each case is reported on an individual basis with the core set of variables. All case reporting is non-nominal.

The Protocol for Interprovincial/Territorial Notification of Disease

  • The jurisdiction where the disease is diagnosed normally reports the case or has the responsibility to make sure that the disease is reported by some jurisdiction.
  • The jurisdiction of diagnosis notifies the jurisdiction of residence if public health action (e.g. contact management, source of identifications, etc.) is necessary in those jurisdictions.
  • Where cases resident in one jurisdiction are being diagnosed in another (such as in border towns) and thereby significantly affecting the incidence rate in the second jurisdiction, the two jurisdictions may make a disease-specific agreement that the diagnosing jurisdiction does not count the cases but does notify the residence jurisdiction, which will count them.
  • Cases moving from one jurisdiction to another while still under surveillance for a notifiable disease are not re-counted in the new jurisdiction.

National Analysis and Reporting

LCDC will publish annual surveillance summaries. Provisional data for the most recent reporting period will continue to be published each quarter in Canada Communicable Disease Report. Disease incidence and rates of infection will be available on LCDC's website under Notifiable Diseases On-Line and can be accessed at the following address: http://www.phac-aspc.gc.ca/dsol-smed/.

TABLE OF CONTENTS

BASIC PRINCIPLES AND METHODS

CASE DEFINITIONS FOR DISEASES UNDER NATIONAL SURVEILLANCE

Enteric, Food and Waterborne Diseases

  • Botulism
  • Campylobacteriosis
  • Cholera 
  • Cryptosporidiosis
  • Cyclosporiasis
  • Giardiasis
  • Hepatitis A
  • Salmonellosis
  • Shigellosis
  • Typhoid
  • Verotoxigenic Escherichia coli Infection

Diseases Transmitted By Direct Contact and Respiratory Routes

  • Classic Creutzfeld-Jakob Disease
  • New Variant Creutzfeld-Jakob Disease
  • Hantavirus Pulmonary Syndrome (HPS)
  • Laboratory-Confirmed Influenza
  • Legionellosis
  • Leprosy (Hansen's Disease)
  • Invasive Meningococcal Disease
  • Invasive Pneumococcal Disease
  • Invasive Group A Streptococcal Disease
  • Group B Streptococcal Disease of the Newborn
  • Tuberculosis

Sexually Transmitted and Bloodborne Pathogens

  • Acquired Immunodeficiency Syndrome (AIDS)
  • Chlamydial Infection
  • Gonorrhea
  • Hepatitis C
  • HIV Infection
  • Syphilis

Vectorborne and Other Zoonotic Diseases

  • Brucellosis
  • Lyme Disease
  • Malaria
  • Plague
  • Rabies
  • Yellow Fever

Diseases Preventable by Routine Vaccination

  • Chickenpox
  • Diphtheria
  • Hepatitis B
  • Invasive Haemophilus Influenzae type b (Hib) Disease
  • Measles
  • Mumps
  • Acute Flaccid Paralysis (AFP)
  • Pertussis
  • Poliomyelitis
  • Rubella
  • Congenital Rubella Syndrome (CRS)
  • Tetanus    

Worldwide Potential Bioterrorism Agents

  • Anthrax
  • Botulism
  • Plague
  • Smallpox
  • Tularemia
  • Viral Hemorrhagic Fevers

Case Definitions for Diseases Under National Surveillance
PDF Version PDF
(73 Pages, 1,827 KB)

 

prepared by the

Advisory Committee on Epidemiology

and the

Division of Disease Surveillance
Bureau of Infectious Diseases
Laboratory Centre for Disease Control
Health Protection Branch
Health Canada

[Table of Contents]


Last Updated: 2006-01-04 Top